publication venue for
- Allogeneic Tumor Antigen-Specific T Cells for Broadly Applicable Adoptive Cell Therapy of Cancer.. 183. 2022
- Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer.. 59. 1992
- Immunogenic Cell Death Driven by Radiation-Impact on the Tumor Microenvironment.. 180. 2020
- Angioimmunoblastic T-Cell Lymphoma.. 176. 2019
- Checkpoint Blockade for the Treatment of Advanced Melanoma.. 167. 2016
- Treatment of Uveal Melanoma.. 167. 2016
- Rare T-cell lymphomas.. 142. 2008
- Eltrombopag. 2011
- Ethicolegal aspects of cancer genetics. 2010
- Principles and overview of allogeneic hematopoietic stem cell transplantation. 2009
- Staging and surgical treatment. 2009
- Polycythemia vera and other polycythemia syndromes. 2008
- Surgical issues and preoperative systemic therapy. 2008
- Patterns of metastasis in human solid cancers. 2007
- Lymphoma imaging: nuclear medicine. 2006
- Pathogenesis of viral lymphomas. 2006
- Pathology of B-cell non-Hodgkin's lymphomas and multiple myeloma. 2006
- Leptomeningeal metastases from leukemias and lymphomas. 2005
- Neurosurgical interventions for leptomeningeal tumor. 2005
- Ceramide and sphingosine 1-phosphate in anti-cancer therapies. 2003
- Monoclonal antibody therapy of kidney cancer. 2003
- Prognostic factors for metastatic kidney cancer. 2003
- Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy. 2002
- Biology of non-Hodgkin's lymphoma. 2001
- Surgery for non-small cell lung cancer. 2001
- Non myeloablative "mini transplants". 1999
- Adjuvant chemotherapy in gastric adenocarcinomas. 1998
- Computer-controlled delivery of 3D conformal radiation treatments. 1998
- Health services research in head and neck cancer. 1998
- Minimally invasive surgery in surgical oncology. 1997
- New developments in soft tissue sarcoma. 1997
- New antineoplastic agents in lung cancer 1988-1993. 1995
- Imaging and dosimetry determinations using radiolabeled antibodies. 1993
- Monoclonal antibodies in the treatment of myelogenous leukemias. 1993
- Osteosarcoma of the extremities: chemotherapy experience at Memorial Sloan-Kettering. 1993
- The role of surgery in cutaneous malignant melanoma. 1993
- Treatment of leukemia with radiolabeled monoclonal antibodies. 1993
- Suramin as an archetypical compound in the development of growth factor antagonists for inhibition of genitourinary tumors. 1992
- The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer. 1991
- Tumor targeting with monoclonal antibody B72.3: experimental and clinical results. 1990
- Primary central nervous system lymphomas. 1989
- Systemic chemotherapy in the management of bladder cancer. 1989
- Flutamide and other antiandrogens in the treatment of advanced prostatic carcinoma. 1988
- Radioimmunoscintigraphy of lymphoma with monoclonal antibodies. 1988
- Lysophosphatidic acid and invasion. 2009
- Reduced-intensity and nonmyeloablative conditioning regimens. 2009
- Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancer. 2009
- Mantle cell lymphoma: current concept in biology and treatment. 2006
- Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma. 2006
- Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer. 2002
- Early detection of ovarian cancer: promise and reality. 2002
- The scientific basis of early detection of epithelial ovarian cancer: the National Ovarian Cancer Early Detection Program (NOCEDP). 2002
- Ultrasound and ovarian cancer. 2002
- Biology of liver metastases. 2001
- Autologous bone marrow transplantation for leukemia and lymphoma. 1996
- Treatment of relapse after allogeneic bone marrow transplantation. 1996
- Evolving concepts in the adjuvant systemic therapy of operable breast cancer. 1992